EDGAR Filing Documents for 0001171843-15-001491

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001171843-15-001491

Filing Date

2015-03-18

Accepted

2015-03-18 21:37:40

Documents

Period of Report

2015-03-11

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	gff4_ashton031815.html	4
1	OWNERSHIP DOCUMENT	gff4_ashton031815.xml	4	43349
	Complete submission text file	0001171843-15-001491.txt		44724

Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814

Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400

Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUCAMPO PHARMACEUTICALS, INC. 4520 EAST WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814

Business Address

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 15711515